Cargando…

The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease

OBJECTIVE: We calculated the short- and long-term care resource use and costs in adults with high-risk conditions for cardiovascular disease (HRCVD) as defined by the Canadian Cardiovascular Society dyslipidemia guidelines. METHODS: We linked Alberta health databases to identify patients aged ≥ 18 y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Dat T., Palfrey, Dan, Welsh, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333236/ https://www.ncbi.nlm.nih.gov/pubmed/33484443 http://dx.doi.org/10.1007/s41669-021-00257-8

Ejemplares similares

The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada
por: Tran, Dat T., et al.
Publicado: (2017)

The Current and Future Hospitalization Cost Burden of Syncope in Canada
por: Tran, Dat T., et al.
Publicado: (2020)

Prevalence of Cardiovascular Disease in a Population-Based Cohort of High-Cost Healthcare Services Users
por: Kaul, Padma, et al.
Publicado: (2021)

Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study
por: Bernfort, Lars, et al.
Publicado: (2020)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Estimated cost for cardiovascular disease risk-based management at a primary healthcare center in Nepal
por: Aryal, Anu, et al.
Publicado: (2020)

Economic burden of multimorbidity among older adults: impact on healthcare and societal costs
por: Picco, Louisa, et al.
Publicado: (2016)

Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States
por: Collier, Sarah A., et al.
Publicado: (2021)

Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina
por: Rubinstein, Adolfo, et al.
Publicado: (2010)

Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups
por: Rafferty, Ellen, et al.
Publicado: (2022)

Association of sitting time and cardiorespiratory fitness with cardiovascular disease risk and healthcare costs among office workers
por: SO, Rina, et al.
Publicado: (2022)

Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer’s Disease Patients
por: Qureshi, Zaina P., et al.
Publicado: (2021)

Association of Cardiovascular Risk Burden With Risk and Progression of Disability: Mediating Role of Cardiovascular Disease and Cognitive Decline
por: Cui, Kaiwang, et al.
Publicado: (2020)

The Costs of Industry-Sponsored Drug Trials in Canada
por: Tran, Dat T., et al.
Publicado: (2019)

Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US
por: Edelman, Steve, et al.
Publicado: (2020)

Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk
por: Huang, Wan-Chun, et al.
Publicado: (2021)

Conventional and Complementary Healthcare Utilization Among US Adults With Cardiovascular Disease or Cardiovascular Risk Factors: A Nationally Representative Survey
por: Kohl, Wiebke Kathrin, et al.
Publicado: (2020)

The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran
por: Mokhtari, Mehdi, et al.
Publicado: (2022)

Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States
por: DeFlorio-Barker, Stephanie, et al.
Publicado: (2021)

The rising cost of healthcare and its contribution to the worsening disease burden in developing countries
por: Fazal, Faizan, et al.
Publicado: (2022)

Nutritional adequacy and dietary disparities in an adult Caribbean population of African descent with a high burden of diabetes and cardiovascular disease
por: Harris, Rachel M., et al.
Publicado: (2020)

Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease
por: Angell, Blake, et al.
Publicado: (2017)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Association between sociodemographic status and cardiovascular risk factors burden in community populations: implication for reducing cardiovascular disease burden
por: Cai, Anping, et al.
Publicado: (2022)

Economic burden of cardiovascular diseases in the European Union: a population-based cost study
por: Luengo-Fernandez, Ramon, et al.
Publicado: (2023)

The Burden of Cardiovascular Disease Attributable to Major Modifiable Risk Factors in Indonesia
por: Hussain, Mohammad Akhtar, et al.
Publicado: (2016)

The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysis
por: Lalayiannis, Alexander D, et al.
Publicado: (2021)

Incremental healthcare cost burden in patients with atrial flutter only
por: Kim, Kathryn M., et al.
Publicado: (2023)

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
por: Bonafede, Machaon M, et al.
Publicado: (2015)

Economic burden of Cardiac Arrest in Spain: analyzing healthcare costs drivers and treatment strategies cost-effectiveness
por: Matilla-García, Mariano, et al.
Publicado: (2023)

Modeling the burden of cardiovascular disease in Turkey
por: Balbay, Yücel, et al.
Publicado: (2018)

Sodium and potassium excretion in an adult Caribbean population of African descent with a high burden of cardiovascular disease
por: Harris, Rachel M., et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada
por: Grégoire, Jean, et al.
Publicado: (2022)

Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease
por: Galactionova, Katya, et al.
Publicado: (2022)

Risk factors associated with cardiovascular disease among adult Nevadans
por: Tran, Dieu-My T., et al.
Publicado: (2021)

Significant healthcare burden and life cost of spinal muscular atrophy: real-world data
por: Chan, Sophelia H. S., et al.
Publicado: (2022)

Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
por: Lozano-Ortega, Greta, et al.
Publicado: (2020)

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
por: Setyawan, Juliana, et al.
Publicado: (2021)

Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry
por: Wittbrodt, Eric, et al.
Publicado: (2020)

Prevalence of high-burden medical conditions and health care resource utilization and costs among adults with cerebral palsy
por: Whitney, Daniel G, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_prv3vi5gp09mgihqg41mnml4lj